Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DGKα-IN-2 (example 48), a potent DGKα inhibitor with an IC50 of 0.9 nM, exhibits potential for cancer and immunological research by significantly augmenting the anti-tumor efficacy of anti-PD-1 therapy through the amplification of T cell proliferation and function.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | DGKα-IN-2 (example 48), a potent DGKα inhibitor with an IC50 of 0.9 nM, exhibits potential for cancer and immunological research by significantly augmenting the anti-tumor efficacy of anti-PD-1 therapy through the amplification of T cell proliferation and function. |
Molecular Weight | 461.43 |
Formula | C23H22F3N3O4 |
CAS No. | 2648556-92-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DGKα-IN-2 2648556-92-5 inhibitor inhibit